AGP Picks
View all

World Healthcare Report
Provided by AGP

World Healthcare Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Healthcare Report.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on May 8, 2026

Hyperion DeFi Announces Closing of Public Offering of Common Stock
May 8, 2026

Hyperion DeFi Announces Closing of Public Offering of Common Stock

Indeterminate GlobeNewswire
Tvardi Therapeutics Announces First Quarter 2026 Results and Provides Business Update
May 8, 2026

Tvardi Therapeutics Announces First Quarter 2026 Results and Provides Business Update

Indeterminate GlobeNewswire
MapLight Therapeutics to Participate in Upcoming Investor Conferences
May 8, 2026

MapLight Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Artiva Biotherapeutics Announces Pricing of $300 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
May 8, 2026

Artiva Biotherapeutics Announces Pricing of $300 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

Indeterminate GlobeNewswire
ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance
May 8, 2026

ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance

Indeterminate GlobeNewswire
Artiva Biotherapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights
May 8, 2026

Artiva Biotherapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire
Knight Therapeutics Announces Regulatory Approval of TAVALISSE® in Brazil
May 8, 2026

Knight Therapeutics Announces Regulatory Approval of TAVALISSE® in Brazil

Indeterminate GlobeNewswire
Thérapeutique Knight annonce l’approbation réglementaire de TAVALISSE® au Brésil
May 8, 2026

Thérapeutique Knight annonce l’approbation réglementaire de TAVALISSE® au Brésil

Indeterminate GlobeNewswire
Artiva Announces Positive Initial Clinical Data with AlloNK® Across Multiple Autoimmune Diseases and FDA Alignment to Initiate Phase 3 Registrational Trial in Rheumatoid Arthritis in 2026
May 8, 2026

Artiva Announces Positive Initial Clinical Data with AlloNK® Across Multiple Autoimmune Diseases and FDA Alignment to Initiate Phase 3 Registrational Trial in Rheumatoid Arthritis in 2026

Indeterminate GlobeNewswire
Nxera Files Patent Infringement Action in Relation to its miniG Platform Technology
May 8, 2026

Nxera Files Patent Infringement Action in Relation to its miniG Platform Technology

Indeterminate GlobeNewswire
ANGEL Expands U.S. Water Purification Lineup with New Whole House Water Filtration Systems
May 8, 2026

ANGEL Expands U.S. Water Purification Lineup with New Whole House Water Filtration Systems

Indeterminate GlobeNewswire
Profusa Receives Favorable Nasdaq Listing Determination
May 8, 2026

Profusa Receives Favorable Nasdaq Listing Determination

Indeterminate GlobeNewswire
Pharvaris Announces Pricing of $115 Million Underwritten Offering of Ordinary Shares
May 8, 2026

Pharvaris Announces Pricing of $115 Million Underwritten Offering of Ordinary Shares

Indeterminate GlobeNewswire
Update on FDA Priority Review of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection as a Starting Dose for Early Alzheimer’s Disease
May 8, 2026

Update on FDA Priority Review of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection as a Starting Dose for Early Alzheimer’s Disease

Indeterminate GlobeNewswire
LifeStance Health Group Announces Pricing of Secondary Public Offering
May 8, 2026

LifeStance Health Group Announces Pricing of Secondary Public Offering

Indeterminate GlobeNewswire
Mobia Medical Announces Pricing of Initial Public Offering
May 8, 2026

Mobia Medical Announces Pricing of Initial Public Offering

Indeterminate GlobeNewswire
Odyssey Therapeutics Announces Pricing of Upsized Initial Public Offering
May 8, 2026

Odyssey Therapeutics Announces Pricing of Upsized Initial Public Offering

Indeterminate GlobeNewswire
InnoCare Announces Approval of a Phase II Clinical Trial of TYK2 Inhibitor ICP-488 for Sjögren's Syndrome in China
May 8, 2026

InnoCare Announces Approval of a Phase II Clinical Trial of TYK2 Inhibitor ICP-488 for Sjögren's Syndrome in China

Indeterminate GlobeNewswire
MediPharm Labs Sets Date to Report First Quarter 2026 Financial Results
May 8, 2026

MediPharm Labs Sets Date to Report First Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

World Healthcare Report

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.